ArticleFrontiers in medicine2022

Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2.

Heidi Auerswald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.